National Toxicology Program Studies Support the Safety of Chromium Picolinate

Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.

16/09/08 Nutrition 21, Inc., the developer and marketer of nutritional supplements under the Iceland Health Chromax, and Diabetes Essentials brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and reduce chronic joint pain, reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements. Results of the studies can be viewed at the NTP website at: http://ntp.niehs.nih.gov/?objectid=BD466797-123F-7908-7B4627379E1CE3E6.

Michael A. Zeher, president and chief executive officer of Nutrition 21, commented, “We are pleased with the conclusions of the NTP studies. Over the years Chromax chromium picolinate has proven to be an efficacious compound in assisting consumers to safely and proactively attain, and maintain, healthy blood glucose levels, carbohydrate metabolism, and body composition. Chromax chromium picolinate is used as a nutritional ingredient in a wide variety of dietary supplements and functional food and beverage products from leading manufacturing companies. The results of these highly credible studies build upon the extensive database of safety data behind our products, and help provide retailers and consumers with the added confidence they need to initially buy our product and to become loyal repeat customers."

“The results from the NTP studies are very significant in that chromium picolinate did not cause any dose-related safety issues, even when used at extremely high doses taken over prolonged periods of time," stated toxicology expert Dr. Ron Slesinski, PhD., DABT, past President of the Regulatory and Safety Specialty Section of the Society of Toxicology. “I believe that the safety profile of chromium picolinate is firmly established by the results of these independent studies.”

James Komorowski, M.S., vice president – technical services and scientific affairs for Nutrition 21, concluded, "No other form of nutritional chromium on the market today has been as thoroughly tested as Chromax chromium picolinate. We believe that these results validate our operational philosophy of combining high quality science and ground-breaking technology to develop superior nutritional products.”